Well‐Defined, Reversible Boronate Crosslinked Nanocarriers for Targeted Drug Delivery in Response to Acidic Ph Values and Cis‐diols
Yuanpei Li,Wenwu Xiao,Kai Xiao,Lorenzo Berti,Juntao Luo,Harry P. Tseng,Gabriel Fung,Kit S. Lam
DOI: https://doi.org/10.1002/ange.201107144
2012-01-01
Angewandte Chemie
Abstract:Angewandte ChemieVolume 124, Issue 12 p. 2918-2923 Zuschrift Well-Defined, Reversible Boronate Crosslinked Nanocarriers for Targeted Drug Delivery in Response to Acidic pH Values and cis-Diols† Dr. Yuanpei Li, Dr. Yuanpei Li Department of Biochemistry and Molecular Medicine, UC Davis Cancer Center, University of California, Davis, 2700 Stockton Blvd., Sacramento, CA 95817 (USA) These authors contributed equally to this work.Search for more papers by this authorDr. Wenwu Xiao, Dr. Wenwu Xiao Department of Biochemistry and Molecular Medicine, UC Davis Cancer Center, University of California, Davis, 2700 Stockton Blvd., Sacramento, CA 95817 (USA) These authors contributed equally to this work.Search for more papers by this authorDr. Kai Xiao, Dr. Kai Xiao Department of Biochemistry and Molecular Medicine, UC Davis Cancer Center, University of California, Davis, 2700 Stockton Blvd., Sacramento, CA 95817 (USA)Search for more papers by this authorDr. Lorenzo Berti, Dr. Lorenzo Berti Department of Biochemistry and Molecular Medicine, UC Davis Cancer Center, University of California, Davis, 2700 Stockton Blvd., Sacramento, CA 95817 (USA)Search for more papers by this authorProf. Juntao Luo, Corresponding Author Prof. Juntao Luo luoj@upstate.edu Department of Pharmacology, SUNY Upstate Cancer Research Institute, SUNY Upstate Medical University, Syracuse, NY 13210 (USA) Juntao Luo, Department of Pharmacology, SUNY Upstate Cancer Research Institute, SUNY Upstate Medical University, Syracuse, NY 13210 (USA) Kit S. Lam, Department of Biochemistry and Molecular Medicine, UC Davis Cancer Center, University of California, Davis, 2700 Stockton Blvd., Sacramento, CA 95817 (USA)Search for more papers by this authorHarry P. Tseng, Harry P. Tseng Department of Biochemistry and Molecular Medicine, UC Davis Cancer Center, University of California, Davis, 2700 Stockton Blvd., Sacramento, CA 95817 (USA)Search for more papers by this authorGabriel Fung, Gabriel Fung Department of Biochemistry and Molecular Medicine, UC Davis Cancer Center, University of California, Davis, 2700 Stockton Blvd., Sacramento, CA 95817 (USA)Search for more papers by this authorProf. Kit S. Lam, Corresponding Author Prof. Kit S. Lam kit.lam@ucdmc.ucdavis.edu Department of Biochemistry and Molecular Medicine, UC Davis Cancer Center, University of California, Davis, 2700 Stockton Blvd., Sacramento, CA 95817 (USA) Juntao Luo, Department of Pharmacology, SUNY Upstate Cancer Research Institute, SUNY Upstate Medical University, Syracuse, NY 13210 (USA) Kit S. Lam, Department of Biochemistry and Molecular Medicine, UC Davis Cancer Center, University of California, Davis, 2700 Stockton Blvd., Sacramento, CA 95817 (USA)Search for more papers by this author Dr. Yuanpei Li, Dr. Yuanpei Li Department of Biochemistry and Molecular Medicine, UC Davis Cancer Center, University of California, Davis, 2700 Stockton Blvd., Sacramento, CA 95817 (USA) These authors contributed equally to this work.Search for more papers by this authorDr. Wenwu Xiao, Dr. Wenwu Xiao Department of Biochemistry and Molecular Medicine, UC Davis Cancer Center, University of California, Davis, 2700 Stockton Blvd., Sacramento, CA 95817 (USA) These authors contributed equally to this work.Search for more papers by this authorDr. Kai Xiao, Dr. Kai Xiao Department of Biochemistry and Molecular Medicine, UC Davis Cancer Center, University of California, Davis, 2700 Stockton Blvd., Sacramento, CA 95817 (USA)Search for more papers by this authorDr. Lorenzo Berti, Dr. Lorenzo Berti Department of Biochemistry and Molecular Medicine, UC Davis Cancer Center, University of California, Davis, 2700 Stockton Blvd., Sacramento, CA 95817 (USA)Search for more papers by this authorProf. Juntao Luo, Corresponding Author Prof. Juntao Luo luoj@upstate.edu Department of Pharmacology, SUNY Upstate Cancer Research Institute, SUNY Upstate Medical University, Syracuse, NY 13210 (USA) Juntao Luo, Department of Pharmacology, SUNY Upstate Cancer Research Institute, SUNY Upstate Medical University, Syracuse, NY 13210 (USA) Kit S. Lam, Department of Biochemistry and Molecular Medicine, UC Davis Cancer Center, University of California, Davis, 2700 Stockton Blvd., Sacramento, CA 95817 (USA)Search for more papers by this authorHarry P. Tseng, Harry P. Tseng Department of Biochemistry and Molecular Medicine, UC Davis Cancer Center, University of California, Davis, 2700 Stockton Blvd., Sacramento, CA 95817 (USA)Search for more papers by this authorGabriel Fung, Gabriel Fung Department of Biochemistry and Molecular Medicine, UC Davis Cancer Center, University of California, Davis, 2700 Stockton Blvd., Sacramento, CA 95817 (USA)Search for more papers by this authorProf. Kit S. Lam, Corresponding Author Prof. Kit S. Lam kit.lam@ucdmc.ucdavis.edu Department of Biochemistry and Molecular Medicine, UC Davis Cancer Center, University of California, Davis, 2700 Stockton Blvd., Sacramento, CA 95817 (USA) Juntao Luo, Department of Pharmacology, SUNY Upstate Cancer Research Institute, SUNY Upstate Medical University, Syracuse, NY 13210 (USA) Kit S. Lam, Department of Biochemistry and Molecular Medicine, UC Davis Cancer Center, University of California, Davis, 2700 Stockton Blvd., Sacramento, CA 95817 (USA)Search for more papers by this author First published: 17 January 2012 https://doi.org/10.1002/ange.201107144Citations: 62 † This work was funded by NIH/NCI (R01CA115483 and R01CA140449), NIH/NIBIB (R01EB012569), and DoD BCRP Postdoctoral Award (W81XWH-10-1-0817). Read the full textAboutPDF ToolsRequest permissionAdd to favorites ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Abstract Geliefert wie bestellt: Micellen, die über Boronatester reversibel vernetzt sind (siehe Schema), sind in vivo und in vitro stabil, sodass die vorzeitige Freisetzung des Wirkstoffs unter physiologischen Bedingungen minimiert ist. Nach Erreichen des Tumors wird die Freisetzung des Wirkstoffs (Sterne im Schema) durch Spaltung der Boronatester unter den sauren Bedingungen in der Umgebung des Tumors oder im Zellinneren oder durch die Verabreichung von Mannit aktiviert. Citing Literature Supporting Information Detailed facts of importance to specialist readers are published as "Supporting Information". Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors. Filename Description ange_201107144_sm_miscellaneous_information.pdf2.6 MB miscellaneous_information Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. Volume124, Issue12March 19, 2012Pages 2918-2923 This is the German version of Angewandte Chemie. Note for articles published since 1962: Do not cite this version alone. Take me to the International Edition version with citable page numbers, DOI, and citation export. We apologize for the inconvenience. RelatedInformation